iBio
IBIO
12 hedge funds and large institutions have $2.58M invested in iBio in 2015 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 6 closing their positions.
26% more capital invested
Capital invested by funds: $2.05M → $2.58M (+$524K)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
25% less funds holding
Funds holding: 16 → 12 (-4)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$93K |
| 2 |
Bank of New York Mellon
New York
|
+$13.9K |
| 3 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$9.3K |
| 4 |
Morgan Stanley
New York
|
+$9.3K |
| 5 |
UAS
United Asset Strategies
Garden City,
New York
|
+$9.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$23K |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$18.6K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$17K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$9.3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$9.3K |
IBIO Hedge Fund Activity: Q2 2015 in Review
12 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q2 2015, worth a combined $2.58M — up 26% from $2.05M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of IBIO and 2 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 3 added.
The largest buyer was Vanguard Group, adding an estimated $93K. The largest seller was Virtu KCG Holdings, exiting entirely with an estimated $23K sold.
- 12 institutional investors held iBio (IBIO) as of Q2 2015, down from 16 in Q1 2015.
- Funds reported $2.58M of iBio stock for Q2 2015, up 26% quarter-over-quarter.
- 2 funds opened new iBio positions in Q2 2015 and 6 closed out, a net change of -4 holders.
- The largest iBio buyer in Q2 2015 was Vanguard Group, an estimated $93K added.
- The largest iBio seller in Q2 2015 was Virtu KCG Holdings, an estimated $23K sold.
Based on aggregated 13F filings for Q2 2015.